46
Growth Score in past quarter
pts
Heat Score 46 in past quarter
-14 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
1215231
Opsis Therapeutics is a mission is to develop first-in-class treatments for retinal diseases.
- Rebecca Selzer: President and CEOPast Role: Roche NimbleGen, Site Head and Head of Operations
- Carter Cliff: Co-FounderPast Role: Cellular Dynamics International, Director Business Development
About the Company
Opsis Therapeutics is a company focused on discovering and developing new medicines to restore vision to patients suffering from retinal diseases.